Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

NCT00731679 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

623

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Constipation Irritable Bowel Syndrome

Interventions

DRUG: Rifaximin
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.